PXF stock forecast, quote, news & analysis

The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), BHP Group Limited (NYSE:BHP), AT&T (NYSE:T), BP plc (NYSE:BP), Boeing Company (NYSE:BA), Shopify (NYSE:SHOP), Canadian Natural Resources Limited (NYSE:CNQ), Allergan plc (NYSE:AGN), JD.com (NASDAQ:JD).

The investment seeks to track the investment results (before fees and expenses) of the FTSE RAFITM Developed ex U.S. 1000 Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index, as well as American depositary receipts ("ADRs") and global depositary receipts ("GDRs") that represent securities in the underlying index. The underlying index is comprised of companies located in countries that are classified as "developed" within the country classification definition of FTSE, excluding the United States.

The average market capitalization across the Invesco FTSE RAFI Dev Mkts ex-US ETF ETF is 32.83B. The market cap for tickers in the group ranges from 64.65K to 380.18B. ASML holds the highest valuation in this group at 380.18B. The lowest valued company is BAYN at 64.65K.

The average weekly price growth across all stocks in the Invesco FTSE RAFI Dev Mkts ex-US ETF ETF was -2%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was -3%. NA experienced the highest price growth at 36%, while EBS experienced the biggest fall at -34%.

The average weekly volume growth across all stocks in the Invesco FTSE RAFI Dev Mkts ex-US ETF ETF was 1%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was 1%